Suchergebnisse - "Jarrett, James"

PubPharm (50)

1

Remdesivir for Hospitalized COVID-19 Patients in the United States : Optimization of Health Care Resources

enthalten in: Infectious diseases and therapy | 2023

von Barnieh, L. | Beckerman, R. | Jeyakumar, S. | +3

2

Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources

enthalten in: Infectious diseases and therapy | 2023

von Barnieh, L. | Beckerman, R. | Jeyakumar, S. | +3

3

Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources

enthalten in: Infectious diseases and therapy | 2023

von Barnieh, L. | Beckerman, R. | Jeyakumar, S. | +3

4

Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources

enthalten in: Infectious diseases and therapy | 2023

von Barnieh, L. | Beckerman, R. | Jeyakumar, S. | +3

5

Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates : a cost-effectiveness and health-care resource use analysis

enthalten in: BMC health services research | 2023

von Subhi, A. | Shamy, A. | Hussein, S. | +4

6

Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis

enthalten in: BMC health services research | 2023

von Subhi, A. | Shamy, A. | Hussein, S. | +4

7

Correction to : Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

enthalten in: International journal of clinical pharmacy | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

ErratumFor: Int J Clin Pharm. 2023 Apr;45(2):330-341. - PMID 36484968

8

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19 : a systematic review

enthalten in: Infection | 2023

von Murton, M. | Drane, E. | Jarrett, J. | +2

9

Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis : a systematic review and network meta-analysis

enthalten in: International journal of clinical pharmacy | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

ErratumIn: Int J Clin Pharm. 2023 Mar 19;:. - PMID 36934390

10

Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

enthalten in: Pharmacy world & science | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

1
2
3
4
5
Nächster »
[5]